christian juhl terkelsen

Prof. christian juhl terkelsen

Aarhus University Hospital, Department of cardiology
+2

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2010 in JAMA
Verified
Journal Article
Open access
PDF file
CTchristian juhl terkelsen
christian juhl terkelsen
JSJacob Thorsted Sørensen
Jacob Thorsted Sørensen
MMMichael Maeng
Michael Maeng
LJLisette Okkels Jensen
Lisette Okkels Jensen
HTHans-Henrik Tilsted
Hans-Henrik Tilsted
JLJens Flensted Lassen
Jens Flensted Lassen
Timely reperfusion therapy with either fibrinolysis or primary percutaneous coronary intervention (PCI) is recommended for patients with ST-segment elevation myocardial infarction (STEMI).1 However, agreeing on the definition of “timely” is difficult, because the benefit achieved by earlier initiation of reperfusion therapy is controversial. The only unbiased studies that have evaluated the effects of earlier reperfusion therapy on outcome are randomized controlled studies that compared prehospital and in-hospital fibrinolysis. In those studies, prehospital fibrinolysis was associated with earlier initiation (1 hour) of reperfusion therapy, resulting in an extra 15 to 21 lives saved per 1000 treated patients.2-4 The time-dependent benefit of primary PCI has been evaluated from observational data only, and the nearly neutral relationship observed between treatment delay and mortality may lead to the perception that the effect of primary PCI is less time-dependent than the effect of fibrinolysis.5-7

23 November 2004 in European Heart Journal
Verified
Journal Article
Open access
PDF file
CTchristian juhl terkelsen
christian juhl terkelsen
JLJens Flensted Lassen
Jens Flensted Lassen
BNBjarne Linde Nørgaard
Bjarne Linde Nørgaard
JGJens Christian Gerdes
Jens Christian Gerdes
TJTage Jensen
Tage Jensen
HAHenning Rud Andersen
Henning Rud Andersen
Aims Acute myocardial infarction (AMI) is categorized, according to the presenting electrocardiogram, into non-ST-elevation myocardial infarction (non-STEMI), ST-elevation myocardial infarction (STEMI), or bundle branch block myocardial infarction (BBBMI). Data on the prognostic significance of these categories mainly originate from voluntary based registries or large-scale clinical trials and may be hampered by selection and information bias. The aim of this historical cohort study was to evaluate the prognostic significance of different categories of AMI in an unselected cohort. Methods and results From 1 November 1999 to 31 October 2001, patient records were reviewed from all admissions to hospitals serving a study region with 139 000 inhabitants. An Endpoint Committee determined whether patients fulfilled the European Society of Cardiology criteria of AMI. A total of 654 patients with AMI were identified. The proportion having non-STEMI, STEMI, and BBBMI was 54, 39 and 6%, and the associated 1 year mortality was 31, 21, and 55%, respectively (log rank 54, P<0.001). The more favourable outcome observed in patients with STEMI remained significant according to multivariable analysis (P=0.044). Conclusion In an unselected cohort of patients admitted with AMI, the mortality was considerably higher than expected from voluntary-based registries and large-scale clinical trials. The most favourable outcome is observed in patients with STEMI.

31 January 2005 in European Heart Journal
Verified
Journal Article
Open access
PDF file
CTchristian juhl terkelsen
christian juhl terkelsen
JLJens Flensted Lassen
Jens Flensted Lassen
BNBjarne Linde Nørgaard
Bjarne Linde Nørgaard
JGJens Christian Gerdes
Jens Christian Gerdes
SPSteen Hvitfeldt Poulsen
Steen Hvitfeldt Poulsen
HAHenning Rud Andersen
Henning Rud Andersen
Aims The majority of patients with ST-elevation myocardial infarction (STEMI) are admitted to local hospitals without primary percutaneous coronary intervention (primary PCI) facilities. Acute transferral to an interventional centre is necessary to treat these patients with primary PCI. The present study assessed the reduction in treatment delay achieved by pre-hospital diagnosis and referral directly to an interventional centre. Methods and results Two local hospitals without primary PCI facilities were serving the study region. Pre-hospital diagnoses were established with the use of telemedicine, by ambulance physicians, or by general practitioners. Primary PCI was accepted as the preferred reperfusion therapy in patients with STEMI. From 31 October 2002 to 31 January 2004 all patients transported by ambulance and transferred for primary PCI were registered. Patients with STEMI were divided into three groups: (A) patients diagnosed at a local hospital (n=55), (B) patients diagnosed pre-hospitally and admitted to a local hospital (n=85), and (C) patients diagnosed pre-hospitally and referred directly to the interventional centre (n=21). When comparing group A with group B and C, no difference was found in age, sex, infarct location, or distance from the scene of event to the interventional centre, whereas the median time from ambulance call to first balloon inflation was 41 min shorter in group B compared with group A (P<0.001) and 81 min shorter in group C compared with group A (P<0.001). Conclusion In a cohort of patients scheduled for admission to a local hospital and subsequent transferral to an interventional centre for primary PCI, those diagnosed pre-hospitally had shorter treatment delay compared with those diagnosed in hospital, both in the setting of initial admission to a local hospital, and to an even larger extent in the setting of referral directly to the interventional centre.

20 September 2011 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
CTchristian juhl terkelsen
christian juhl terkelsen
LJLisette Okkels Jensen
Lisette Okkels Jensen
HTHans-Henrik Tilsted
Hans-Henrik Tilsted
STSven Trautner
Sven Trautner
SJSøren Paaske Johnsen
Søren Paaske Johnsen
JLJens Flensted Lassen
Jens Flensted Lassen
In patients with ST-segment elevation myocardial infarction (STEMI), delay between contact with the health care system and initiation of reperfusion therapy (system delay) is associated with mortality, but data on the associated risk for congestive heart failure (CHF) among survivors are limited. To evaluate the association between system delay and the risk for readmissions or outpatient contacts due to CHF after primary percutaneous coronary intervention (PPCI) in patients with STEMI. Historical follow-up study using population-based medical registries. Western Denmark. Patients with STEMI who were transported by emergency medical service from 1 January 1999 to 7 February 2010 and treated with PPCI within 12 hours of symptom onset and who had a system delay of 6 hours or less (n = 7952). The median duration of follow-up was 3.1 years. Cumulative incidence of readmissions or outpatient contacts due to CHF was determined by using competing-risk regression analysis, with death as the competing risk. Crude and adjusted cause-specific hazard ratios for readmissions or outpatient contacts due to CHF were determined for system delay and other covariates. System delays of 60 minutes or less (n = 451), 61 to 120 minutes (n = 3457), 121 to 180 minutes (n = 2655), and 181 to 360 minutes (n = 1389) corresponded with long-term risks for readmissions or outpatient contacts due to CHF of 10.1%, 10.6%, 12.3%, and 14.1%, respectively (P < 0.001). In multivariable analysis, system delay was an independent predictor of readmissions or outpatient contacts due to CHF (adjusted hazard ratio per hour increase in delay, 1.10 [95% CI, 1.02 to 1.17]). In any nonrandomized study, there are risks for selection bias and residual confounding. In patients with STEMI, shorter delay to PPCI is associated with lower risk for readmissions or outpatient contacts due to CHF during follow-up.

13 February 2009 in Heart
Verified
Journal Article
Closed access
PDF file
CTchristian juhl terkelsen
christian juhl terkelsen
ECEvald Høj Christiansen
Evald Høj Christiansen
JSJ T Sørensen
J T Sørensen
SKS D Kristensen
S D Kristensen
JLJ F Lassen
J F Lassen
TNT T Nielsen
T T Nielsen
There is a continuing controversy about the acceptable time-window for primary percutaneous coronary intervention (PPCI) in patients with ST-elevation myocardial infarction (STEMI). Recent American and European guidelines recommend PPCI if the delay in performing PPCI instead of administering fibrinolysis (PCI-related delay) is <60 min and the presentation delay is more than 3 h. Based on a review of the literature, this viewpoint recommends a revision of the guidelines. The evidence supports an acceptable PCI-related delay of 80–120 min and PPCI as the better reperfusion strategy also in the early incomers. Furthermore, the previous assumption that PPCI is less time-dependent than fibrinolysis is questioned. To maximise the number of patients with STEMI eligible for PPCI the optimal logistic may be to establish the diagnosis in the prehospital phase, to bypass local hospitals and re-route patients directly to catheterisation laboratories running 24/7.

17 December 2024 in Circulation
Verified
Journal Article
Open access
EZElric Zweck
Elric Zweck
CHChristian Hassager
Christian Hassager
HEHans Eiskjær
Hans Eiskjær
NMNorman Mangner
Norman Mangner
APAmin Polzin
Amin Polzin
IHInge De Haas
Inge De Haas
BACKGROUND: In DanGer Shock (the Danish–German Cardiogenic Shock trial), use of a microaxial flow pump (mAFP) in patients with ST-segment–elevation myocardial infarction–related cardiogenic shock led to lower all-cause mortality but higher rates of renal replacement therapy (RRT). In this prespecified analysis, rates and predictors of acute kidney injury (AKI) and RRT were assessed. METHODS: In this international, randomized, open-label, multicenter trial, 355 adult patients with ST-segment–elevation myocardial infarction–related cardiogenic shock were randomized to mAFP (n=179) or standard care alone (n=176). AKI was defined according to RIFLE criteria (Risk, Injury, Failure, Loss, and End-stage kidney disease) and assessed using logistic regression models. Use of RRT was assessed accounting for the competing risk of death using Fine-Gray subdistribution hazard models. RESULTS: AKI (RIFLE ≥1) was recorded in 110 patients (61%) in the mAFP group and 79 patients (45%) in the control group ( P <0.01); RRT was used in 75 (42%) and 47 (27%) patients, respectively ( P <0.01). About two-thirds of the RRTs were initiated within the first 24 hours from admission (n=48 [64%] in the mAFP group and n=31 [66%] in the control group). Occurrence of AKI and RRT were associated with higher 180-day mortality in both study arms. At 180 days, all patients alive were free of RRT. mAFP use was associated with higher rates of RRT, even when accounting for competing risk of death (subdistribution hazard, 1.67 [1.18–2.35]). This association was largely consistent among prespecified subgroups. Allocation to mAFP was associated with lower 180-day mortality irrespective of AKI or RRT ( P interaction =0.84). Relevant predictors of AKI in both groups comprised reduced left ventricular ejection fraction, baseline kidney function, shock severity, bleeding events, and positive fluid balance. Predictors of AKI specific to mAFP were suction events, higher pump speed, and longer duration of support. CONCLUSIONS: Shock severity, allocation to mAFP, and device-related complications were associated with an increased risk of AKI. AKI was generally associated with higher mortality, but the allocation to mAFP consistently led to lower mortality rates at 180 days irrespective of the occurrence of AKI with or without RRT initiation. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01633502.